source
- CVS adds Lilly’s Foundayo and Zepbound to formularies, leveling GLP-1 market with NovoCVS Caremark announced it will place Eli Lilly’s new oral GLP-1 drug Foundayo on its formulary starting June 1 and will restore the injectable Zepbound as a preferred option from Oct 1. The change…
- U.S. policy bars Ebola patients from entering country, plans overseas evacuationU.S. health officials announced that any American who contracts Ebola will not be taken to the United States for care. Instead, patients will be moved to undisclosed locations in Europe for treatme…